Staphylococcus aureus infective endocarditis: diagnosis and management guidelines.

Area of Science:

• Infectious Diseases
• Cardiology
• Antimicrobial Therapy

Background:

• Staphylococcus aureus infective endocarditis (SAIE) presents significant morbidity and mortality.
• Increasing incidence of SAIE necessitates heightened clinical suspicion.
• Non-specific clinical features of SAIE require vigilance in S. aureus bacteremia cases.

Purpose of the Study:

• To outline current evidence-based recommendations for managing S. aureus infective endocarditis.
• To provide guidance on optimal antimicrobial therapy duration and agents.
• To emphasize the importance of multidisciplinary collaboration in complex SAIE cases.

Main Methods:

• Review of current evidence regarding antimicrobial treatment of SAIE.
• Analysis of recommended treatment durations for different SAIE classifications (right-sided, left-sided, prosthetic valve).
• Consideration of adjunctive therapies, including initial combination therapy.

Main Results:

• Recommended minimum antimicrobial therapy durations: 2 weeks for right-sided SAIE, 4 weeks for uncomplicated left-sided SAIE, and 6 weeks for complicated or prosthetic valve SAIE.
• Initial 3-5 days of combination therapy (cell-wall active agent plus aminoglycoside) may shorten bacteremia duration, though mortality benefit is unproven.
• Early consultation with cardiology and cardiothoracic surgery is crucial for complicated or prosthetic valve SAIE.

Conclusions:

• SAIE diagnosis requires high index of suspicion, especially in S. aureus bacteremia.
• Tailored antimicrobial therapy duration based on SAIE type is essential.
• Multidisciplinary management and rapid pathogen identification are key to optimizing outcomes in SAIE.